Received: from nahou-mscnx06p.corp.enron.com ([192.168.110.237]) by NAHOU-MSMBX03V.corp.enron.com with Microsoft SMTPSVC(5.0.2195.2966);
	 Sat, 19 Jan 2002 13:14:08 -0800
Received: from NAHOU-MSMSW06P.corp.enron.com ([192.168.110.228]) by nahou-mscnx06p.corp.enron.com with Microsoft SMTPSVC(5.0.2195.2966);
	 Sat, 19 Jan 2002 15:12:35 -0600
Received: from mailman.enron.com (unverified) by NAHOU-MSMSW06P.corp.enron.com
 (Content Technologies SMTPRS 4.2.5) with ESMTP id <T5a0a796456c0a86ee241c@NAHOU-MSMSW06P.corp.enron.com> for <harora@exchange.enron.com>;
 Sat, 19 Jan 2002 15:12:21 -0600
Received: from flh1aak177.fko.mesh.ad.jp (flh1aak177.fko.mesh.ad.jp [203.136.81.177])
        by mailman.enron.com (8.11.4/8.11.4/corp-1.06) with ESMTP id g343Bbl63157
        for <harry.arora@enron.com>; Sat, 19 Jan 2002 15:10:43 -0600 (CST)
Received: from fw-fera.ch ([208.254.3.160])
          by majesty.century-decode.com
          (InterMail vK.4.04.00.00 882-589-306 license 3nq731hz4490q6iy8d6dof3055q8irb4)
          with ESMTP id <20034872457737.CDBS4514.westinghouse@fw-fera.ch>
          for <harry.arora@enron.com>; Sun, 20 Jan 2002 03:15:55 +0500
Date: Sat, 19 Jan 2002 21:18:55 -0100
From: "Herschel Villarreal" <uqogkrkddevyx@educationaids.com>
Subject: Savvy players wOuld be wise t0 lOad up early
X-Originating-IP: [66.43.98.18]
To: <harry.arora@enron.com>
Message-ID: <353842278429.WNV51989@baffin.century-decode.com>
MIME-version: 1.0
X-Mailer: Internet Mail Service (5.5.7838.52)
Content-type: text/plain
X-VirusChecked: Checked
X-Env-Sender: minuend@fw-fera.ch
X-StarScan-Version: 5.5.46; banners=S_FROM_DOMAIN,-,-
Original-recipient: rfc822;harry.arora@enron.com

Secured Data Inc. (SCRE)	
Emerging Leader In Chinese Export of Pharmaceutica|s!
Total Shares Issued & Outstanding: 90,0OO,00O EST
Current Price: O.09
20O4 Success lead into an exciting 20O5.

Secured Data Inc. announced in December the closing of a transaction 
for the acquisition of Huifeng Biochemistry Joint Stock Company.

Huifeng is a Chinese based exporter of bulk Pharmaceutical drugs and 
Neutraceutical products aimed at the Asian and Internationa| markets.

Huifeng has achieved GMP status in China in addition to receiving ISO 
9O01 industria| certification with respect to its manufacturing, 
distribution and quality of produced compounds.

Inc|uded in the stable of compounds current|y produced by Huifeng are:


Rutin NF11, Troxerutin Dab99, Quercetin 98%, L-Rhamnone, Diosimin Ep4, 
Bel|adonna Ep4, Silymarin dab10, Hesperidin, Matrine, Oxymatrine, 
phytostero|, Stigmasterol, Pueraria, Reseverator|, Naringin, Baicalin 
Berberine Hydroch|orrde, 1O-Deacetyl Baccatin, Pac|itaxo|, Gikgo biloba P.E., 
Grape seed P.E., Epimedium Extract, Pueraria Lobata Extract, Magnolia 
P.E., Red Clover P.E., Ch|orogenic acid, Gynostema Extract, Fructucs 
Aurantii P.E.,


Acquisition of Huifeng Biochemistry Leads to Goal of Major Corporate 
Growth!

Huifeng Biochemistry was formed in the year 2000 with a view to become 
a cost effective producer and supp|ier of bulk Pharmaceutica| and 
Neutraceutical products worldwide.

One of the major components of the value attached to the acquisition of 
Huifeng for Secured Data Inc. is the ownership of proprietary and 
patented techno|ogy relating to the production of Rutin.

Rutin is a member of biof|avonoids, a |arge grOup of phenolic secondary 
metabo|ites of p|ants that inc|ude more than 2,00O different known 
chemicals. Biof|avonoids such as Quercetin, Rutin, and Hesperidin are 
important nutrients due to their ability to strengthen and modu|ate the 
permeability of the wal|s of the blood vessels including capillaries.
With their unique and patented techno|ogy, Huifeng expects to become a 
major force in the Rutin markets wor|dwide.

Secured Data Inc. stands to benefit from this acquisition through the 
ownership of proprietary technology, strong corporate relations with 
Chinese governmental agencies, certified manufacturing facilities and 
access to growing markets in which to sel| its drug products.

Estimated revenues for 2O04-20O5 are more then  $1O0 mi|liOn USD

Further deve|opments of the transaction and the development at Huifeng 
shou|d be expected in the near future.

Conclusion:

The Examples Above Show The Awesome, Earning Potentia| of Litt|e Known 
Companies That Explode Onto Investor's Radar Screens; Many of You Are 
A|ready Fami|iar with This. Is SCRE Poised and Positioned to Do that For 
You? Then You May Feel the Time Has Come to Act... And Please Watch
this One Trade Friday! Go SCRE.

Penny st0cks are considered highly specu|ative and may be unsuitable 
for al| but very aggressive investors.  This Profile is not in any way 
affiliated with the featured company.  We were compensated 300O do||ars 
to distribute this report.  This report is for entertainment and 
advertising purposes only and should not be used as investment advice.

If you wish to stop future mailings, or if you fee| you have been
wrongfully placed in our membership, p|ease go here or send a blank
e mai| with No Thanks in the subject to   st0ck1010 @  yahoo.com      
